TAFI: a promising drug target?
Zirlik
Andreas
A
D000818:Animals; D001777:Blood Coagulation; D025901:Carboxypeptidase B2 / Q000627:therapeutic use*; D002268:Carboxypeptidases / Q000037:antagonists & inhibitors; D005342:Fibrinolysis; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D010940:Plant Proteins / Q000378:metabolism; D010960:Plasminogen Activators; D013917:Thrombin / Q000378:metabolism; D013927:Thrombosis / Q000188:drug therapy
D010940:Plant Proteins; D002268:Carboxypeptidases; D025901:Carboxypeptidase B2; D010960:Plasminogen Activators; D013917:Thrombin